[
    [
        {
            "time": "",
            "original_text": "盘点评 | 上海医药、罗欣药业、烨辉医药、翰森制药等多家公司引进新药，它们有何亮点？",
            "features": {
                "keywords": [
                    "上海医药",
                    "罗欣药业",
                    "烨辉医药",
                    "翰森制药",
                    "新药",
                    "引进"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "盘点评 | 上海医药、罗欣药业、烨辉医药、翰森制药等多家公司引进新药，它们有何亮点？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]